The experience of weight gain as a result of taking second-generation antipsychotic medications: The mental health consumer perspective

Journal of Psychiatric and Mental Health Nursing

Volumn 20, Issue 9, 2013, Pages 801-806

  Usher, K ^a   Park, T ^a   Foster, K ^b  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Medication management; Mental health; Psychotropic medications; Qualitative methodology; Weight gain

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; APPETITE; ARTICLE; DRUG EFFECT; EMOTION; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; MENTAL HEALTH; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOTROPIC MEDICATIONS; QUALITATIVE METHODOLOGY; QUALITATIVE RESEARCH; SCHIZOPHRENIA; WEIGHT GAIN; YOUNG ADULT;

MEDICATION MANAGEMENT; MENTAL HEALTH; PSYCHOTROPIC MEDICATIONS; QUALITATIVE METHODOLOGY; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; APPETITE; EMOTIONS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUALITATIVE RESEARCH; SCHIZOPHRENIA; WEIGHT GAIN; YOUNG ADULT;

EID: 84885180153     PISSN: 13510126     EISSN: 13652850     Source Type: Journal    
DOI: 10.1111/jpm.12019     Document Type: Article

References (26)

1. Caelli K. (2000) The changing face of phenomenological research: traditional and American phenomenology in nursing. Qualitative Health Research 10, 366-377.
2. Citrome L., Blonde L. & Damatarca C. (2005) Metabolic issues in patients with severe mental illness. Southern Medical Association 98, 714-720.
3. Dahlberg K., Drew N. & Nyström M. (2001) Reflective Life - World Research. Studentlitteratur, Lund.
4. Fisher J.E. & Happell B. (2009) Implications of evidence-based practice for mental health nursing. International Journal of Mental Health Nursing 18, 179-185.
5. Gray R., Wykes T. & Gournay K. (2002) From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing 9, 277-284.
6. Harrison B. (2004) Nursing consideration in psychotropic medication-induced weight gain. Clinical Nurse Specialist 18, 80-87.
7. International Diabetes Federation (IDF) (2006) The IDF consensus worldwide definition of the Metabolic Syndrome. Available at: http://www.idf.org/ (accessed 8 January 2009).
8. Kinon B.J., Bassonn B.R., Gilmore J.A., etal. (2001) Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. Journal of Clinical Psychiatry 62, 92-100.
9. Lambert T.J.R. & Newcomer J.W. (2009) Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Pharmacological approaches to the management of schizophrenia. Medical Journal of Australia 190 (Suppl. 4), S39-S42.
10. Livingston M. (2011) Psychoses: an evidence-based approach to drug treatment. Prescriber 5, 16-32.
11. Malterud K. & Ulriksen K. (2011) Obesity, stigma, and responsibility in health care: a synthesis of qualitative studies. International Journal of Qualitative Studies in Health and Well-Being 6, 8404. doi: 10.3402/qhw.v6i4.8404
12. McCloughen A. & Foster K. (2011) Weight gain associated with taking psychotropic medication: an integrative review. International Journal of Mental Health Nursing 20, 202-222.
13. McDevitt J., Snyder M., Miller A., etal. (2006) Perceptions of barriers and benefits to physical activity among outpatients in psychiatric rehabilitation. Journal of Nursing Scholarship 38, 50-55.
14. Park T., Usher K. & Foster K. (2011) Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics. International Journal of Mental Health Nursing 20, 428-437.
15. Pogge D.L., Singer M.B. & Harvey P.D. (2005) Rates and predictors of adherence with a typical antipsychotic medication: a follow-up study of adolescent inpatients. Journal of Child and Adolescent Psychopharmacology 15, 901-912.
16. Robson D. & Gray R. (2007) Serious mental Illness and physical health problems: a discussion paper. International Journal of Nursing Studies 44, 457-466.
17. Streubert Speziale H.J. & Rinaldi Carpenter D. (2003) Qualitative Research in Nursing: Advancing the Humanistic Imperative, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia.
18. Tschoner A., Engl J., Laimer M., etal. (2007) Metabolic side effects of antipsychotic medication. International Journal of Clinical Practice 61, 1356-1370.
19. Tweedell D.E., Sutter A. & Doran K. (2004) Managing neuroleptic weight gain: consumers' perspectives. International Journal of Psychosocial Rehabilitation 9, 37-40.
20. Ursin H. & Erikson H.R. (2010) Cognitive activation theory of stress (CATS). Neurosciences and Behavioral Reviews 34, 877-881.
21. Usher K., Jackson D. & O'Brien L. (2007) Shattered dreams: parental experiences of adolescent substance abuse. International Journal of Mental Health Nursing 16, 422-430.
22. Van Manen M. (1990) Researching Lived Experience: Human Science for an Action Sensitive Pedagogy. Althouse, Ontario.
23. Vandyk A.D. & Baker C. (2012) Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain. International Journal of Mental Health Nursing 21, 349-357.
24. Weiden P.J., Mackell J.A. & McDonnel D.D. (2004) Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research 66, 51-57.
25. Weissman E.M., Moot D.M. & Essock S.M. (2006) What do people with schizophrenia think about weight management? Psychiatric Service 57, 722-725.
26. Xiao S., Baker C. & Okewumi L.K. (2012) Psychosocial processes influencing weight management among persons newly prescribed atypical antipsychotic medications. Journal of Psychiatric and Mental Health Nursing 19, 241-247.